(Q45882929)

English

A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Abdel-Wahab Z

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Weltz C

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Hester D

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Pickett N

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Vervaert C

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Barber JR

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Jolly D

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Seigler HF

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

80

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

401-412

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Melanoma antigens: immunological and biological characterization and clinical significance

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Immunological memory induced by genetically transduced tumor cells.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Retrovirus-mediated gene transfer of the human gamma-IFN gene: a therapy for cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Selective activation of Th1- and Th2-like cells in vivo--response to human collagen IV.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Cytokines and the Th1/Th2 paradigm in transplantation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Tumor immunotherapy: the tumor cell as an antigen-presenting cell

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Active-specific immunotherapy for melanoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Mammalian tyrosinase: isozymic forms of the enzyme.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C401%3A%3AAID-CNCR8%3E3.0.CO%3B2-U

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19970801)80:3<401::AID-CNCR8>3.0.CO;2-U

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9241074

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45882929&oldid=2088347975"